Acadia Healthcare Company, Inc.

ACHC Healthcare Medical Care Facilities

Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024.

Revenue
+5.14%
EPS
−5.00%
Free cash flow
+196.5%
Total debt
+1.87%

Quarter to September 2026, against a year earlier

34.86 2.61 +8.09%
Market cap
$3.2B
P/E
0.0×
Fwd P/E
34.4×
Dividend yield
—
F-score
5/9
Altman Z
0.92
Beneish M
−3.58
Dividend safety
2/100

Acadia Healthcare Company, Inc. (ACHC) EBITDA

Alert me on EBITDA

Acadia Healthcare Company, Inc.'s EBITDA for fiscal 2025 was $582.1M, down 13.9% from $676.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $539.9M. Over the past ten years it has ranged from $391.1M (fiscal 2015) to $676.0M (fiscal 2024); the current reading is higher than 55% of that period. Acadia Healthcare Company, Inc. ranks 11th of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $582.1M (13.89%)
FY2024 $676.0M 4.20%
FY2023 $648.7M 10.18%
FY2022 $588.7M 12.08%
FY2021 $525.3M 10.93%
FY2020 $473.5M 14.37%
FY2019 $414.0M 4.46%
FY2018 $396.3M (32.91%)
FY2017 $590.7M 0.03%
FY2016 $590.6M 51.01%

Quarterly newest first

Period EBITDA Change
Jun 2026 $139.5M 1.41%
Mar 2026 $137.5M 45.14%
Dec 2025 $94.7M (43.68%)
Sep 2025 $168.2M (12.62%)
42 more quarters

Against its own ten years

Low $391.1M High $676.0M
Ten-year median $582.1M
Current reading's percentile 55

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on ACHC